Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alnylam Pharma (0HD2) vs. Competitors

4 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0HD2Alnylam Pharma$165.50$20.98B8.10-63.29%Moderate BuyUnlock the GB:0HD2 analyst price target with TipRanks PremiumGB:0HD2Unlock the GB:0HD2 top-analyst price target with TipRanks Premium
ARWRArrowhead Pharmaceuticals$47.78$6.66B-9.3716.14%Strong BuyUnlock the ARWR analyst price target with TipRanks PremiumGB:0HD2 vs ARWRUnlock the ARWR top-analyst price target with TipRanks Premium
BMRNBioMarin Pharmaceutical$57.23$10.98B-635.895.55%Moderate BuyUnlock the BMRN analyst price target with TipRanks PremiumGB:0HD2 vs BMRNUnlock the BMRN top-analyst price target with TipRanks Premium
IONSIonis Pharmaceuticals$29.06$4.55B-8.75-58.39%Strong BuyUnlock the IONS analyst price target with TipRanks PremiumGB:0HD2 vs IONSUnlock the IONS top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.70$1.48B-2.9011.88%HoldUnlock the NTLA analyst price target with TipRanks PremiumGB:0HD2 vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
CRSPCrispr Therapeutics AG$42.24$4.13B-8.91-17.35%Moderate BuyUnlock the CRSP analyst price target with TipRanks PremiumGB:0HD2 vs CRSPUnlock the CRSP top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0HD2Alnylam Pharma165.50-297.49-64.25%
ARWRArrowhead Pharmaceuticals47.787.6319.00%
BMRNBioMarin Pharmaceutical57.232.775.09%
IONSIonis Pharmaceuticals29.06-44.20-60.33%
NTLAIntellia Therapeutics9.701.2214.39%
CRSPCrispr Therapeutics AG42.24-13.08-23.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts